Drug Trial Radar · NCT05610891
Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG
Last checked: Nov 19, 2026Latest source record: Oct 1, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
50
Planned (sponsor's estimate)
Start
Oct 1, 2023
Primary completion
Jun 30, 2027
Study completion Dec 2027
Sponsor
- Lead sponsor
- Cellectar Biosciences, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Nov 9, 2022
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 10 years, up to 25 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this dose finding study is to evaluate the safety and efficacy of 2 different dose levels of CLR 131 in children, adolescents and young adults with relapsed or refractory high-grade glioma (HGG).
Conditions
- High-Grade Glioma
Interventions
CLR 131Drug
CLR 131 will be administered IV (intravenously) at a dose based on patients' BSA
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety Evaluation of CLR 131Time frame: Assessed throughout the study to 1-year post-infusion follow-up period
- Efficacy Evaluation for Progression Free SurvivalTime frame: Day 84 post-infusion follow-up period through 3 years following completion of treatment.
Locations
8 sites in 2 countries. Site status is shown where the registry gives one.
Stanford University
Palo Alto, California
Memorial Sloan Kettering Cancer Center
New York, New York
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania
UT Southwestern Medical Center
Dallas, Texas
Texas Children's Cancer Center, Baylor College of Medicine
Houston, Texas
University of Wisconsin, Carbone Cancer Center
Madison, Wisconsin
Hospital for Sick Children
Toronto, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.